Bellevue Asset Management, LLC Heron Therapeutics, Inc. Transaction History

Bellevue Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	SELL	$4.63 - $9.94 $763 - $1,640	-165 Closed	0 $0
Q4 2021 Feb 03, 2022	SELL	$8.35 - $12.6 $116 - $176	-14 Reduced 7.82%	165 $2,000
Q2 2021 Aug 09, 2021	SELL	$13.27 - $18.48 $278 - $388	-21 Reduced 10.5%	179 $3,000
Q1 2021 May 12, 2021	SELL	$14.49 - $20.72 $304 - $435	-21 Reduced 9.5%	200 $3,000
Q4 2020 Feb 11, 2021	SELL	$14.61 - $22.14 $745 - $1,129	-51 Reduced 18.75%	221 $4,000
Q1 2020 May 13, 2020	BUY	$10.23 - $24.56 $2,782 - $6,680	272 New	272 $4,000

180

121M

80.4K

94.9K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $127M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Bellevue Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bellevue Asset Management, LLC with notifications on news.